Comparison 22. Endoflas pulpectomy versus zinc oxide eugenol (ZOE) pulpectomy.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Clinical failure	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
1.1 6 months	2	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.26 [0.05, 1.50]
2 Radiological failure	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
2.1 6 months	2	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.26 [0.05, 1.50]
3 Pain	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
3.1 6 months	2	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.26 [0.05, 1.50]
4 Pathologic mobility	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
4.1 6 months	2	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.16 [0.02, 1.25]
5 Pathologic radiolucency	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
5.1 6 months	2	80	Risk Ratio (M‐H, Fixed, 95% CI)	0.64 [0.11, 3.63]